Home > Healthcare > Medical Devices > Diagnostic Devices > Remote Cardiac Monitoring Market

Remote Cardiac Monitoring Market Trends

Report ID: GMI6021
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Remote Cardiac Monitoring Market Trends

The growing disposable income and healthcare expenditure in emerging countries will accelerate the market trends. Increasing spending ability of population on advanced cardiovascular devices with growing disposable income in developed as well as some developing nations will benefit the adoption of remote patient monitoring devices. For instance, in New Zealand, average annual household disposable income increased by 2.9% than previous year for year ended June 2020. In addition, rising overall healthcare expenditure led to adoption of innovative technologies in treatment facilities. This allowed the physicians to improve healthcare access, optimize procedural time and reduce overall treatment cost. This has resulted in increasing demand for remote cardiac monitoring devices and is anticipated to drive market expansion.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Global market for remote cardiac monitoring was over USD 3 billion in 2022 and will reach more than USD 10 billion by 2032, backed by the rising incidence of heart diseases.

The devices segment will witness more than 11.6% CAGR from 2023 to 2032 due to the continuous technological advancements and integration of AI into devices for enhanced accuracy & interpretation.

U.S. remote cardiac monitoring market size was around USD 1.3 billion in 2022, attributed to significant healthcare expenditure, supportive government initiatives, rising disease awareness, etc.

Abbott Laboratories, AMC Health, Biotronik, Inc., Boston Scientific Corporation, GE Healthcare, Honeywell International Inc., Koninklijke Philips N.V., Medtronic, Nihon Kohden Corporation, OSI Systems, Inc. among others.